Photodynamic cystoscopy for detection of bladder tumors

Surgical Innovation

Volumn 6, Issue 2, 1999, Pages 100-103

  Kriegmair, Martin ^a,b,c   Zaak, Dirk ^a,b,c   Knuechel, Ruth ^a,b,c   Baumgartner, Reinhold ^a,b,c   Hofstetter, Alfons ^a,b,c  

^a Department of Urologv   (Germany)

^b University of Regercrburg   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

5 Aminolevulinic acid; Bladder cancer; Photosensitizer; Preneoplasia; Protoporphyrin IX

Indexed keywords

AMINOLEVULINIC ACID; DIAGNOSTIC AGENT; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ADENOCARCINOMA; ARTICLE; BIOPSY; BLADDER TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIFFERENTIAL DIAGNOSIS; FIBER OPTICS; FLUORESCENCE; FOLLOW UP; HUMAN; INTRAVESICAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; UROTHELIUM;

ADENOCARCINOMA, PAPILLARY; ADMINISTRATION, INTRAVESICAL; AMINOLEVULINIC ACID; BIOPSY; CYSTOSCOPY; DIAGNOSIS, DIFFERENTIAL; FIBER OPTICS; FLUORESCENCE; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 79959661429     PISSN: 15533506     EISSN: 15533514     Source Type: Journal    
DOI: 10.1177/155335069900600209     Document Type: Article

References (27)

1. Kennedy JC, Pottier RH: Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 14:275-292, 1992.
2. Kriegmair M., Baumgartner R., Hofstetter AG: Intravesikale Instillation von Delta-Aminolävulinsäure (ALA)-Eine neue Methode zur photodynamischen Diagnostik und Therapie. Laser Medizin 8:83, 1992.
3. Peng O., Warloe T., Berg K.,et al:5-Aminolevulinic acid-based photodynamic therapy: Clinical research and future challenges. Cancer 79:2282-2308, 1997.
4. Klän R., Loy V., Huland H.: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146:316-318,1991.
5. Köhrmann KU, Woeste M., Kappes J.,et al:Der Wert der transurethralen Nachresektion beim oberflächlichen Harnblasenkarzinom. Akt Urol 25:208-211, 1994.
6. Vögeli TA, Grimm MO, Ackermann R.: Prospective study for quality control of TUR of bladder tumors by routine 2nd TUR (ReTUR).J Urol 159:143, 1998 (suppl).
7. Mersdorf A., Brauers A., Wolf JM,et al:2nd TUR for superficial bladder cancer: A must. J Urol 159:143, 1998 (suppl).
8. Fitzpatrick JM, West AB, Butler MR,et al:Superficial bladder tumors (stage pTa grades 1 and 2): The importance of recurrence pattern following initial resection. J Urol 135:920-922, 1986.
9. Pryor JP: Factors influencing the survival of patients with transitional cell tumours of the urinary bladder. Br J Urol 45:586-592, 1973.
10. Brausi M., Kurth K.-H, VanderMeyden AP,et al:Variability in the three-months recurrence rate after TUR in superficial cell carcinoma (TCC) of the bladder: A combined analysis of 8 EORTC studies. J Urol 159:143, 1998 (suppl).
11. Smith G., Elton RA, Beynon LL,et al:Prognostic significance of biopsy results of normal-looking mucosa in cases of superficial bladder cancer. BrJ Urol 55:665-669, 1983.
12. Heney NM, Ahmed S., Flanagan MJ,et al:Superficial bladder cancer: Progression and recurrence. J Urol 130:1083-1086, 1983.
13. Flamm J., Dona S.: The significance of bladder quadrant biopsies in patients with primary superficial bladder carcinoma. Eur Urol 2:81-85, 1989.
14. Kiemeney LA, Witjes JA, Heijbroek RP,et al:Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 150:60-64, 1993.
15. Kiemeney LA, Witjes JA, Heijbroek RP,et al:Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. Br J Urol 73:164-171, 1994.
16. Sarosdy MF, DeVere White RW, Soloway M.,et al:Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154:379-383, 1995.
17. Vicente J., Chechile G., Algaba F.: Value of in vivo mucosa-staining test with methylene blue in the diagnosis of pretumoral and tumoral lesions of the bladder. Eur Urol 13:15-16, 1987.
18. Kriegmair M., Baumgartner R., Knuechel R.,et al:Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44: 836-841, 1994.
19. Kriegmair M., Stepp H., Steinbach P.,et al:Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: A new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. Urol Int 55:190-196, 1995.
20. Kriegmair M., Baumgartner R., Knuchel R.,et al:Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol 155:105-109, 1996.
21. Rick K., Sroka R., Stepp H.,et al:Pharmacokinetics of 5-aminolevulinic acid induced protoporphyrin IX in skin and blood. J Photochem Photobiol B 40:313-319, 1997.
22. Jichlinski P., Forrer M., Mizeret J.,et al:Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin IX following the topical application of 5-aminolevulinic acid: Preliminary results. Lasers. Surg Med 20:402-408,1997.
23. Filbeck T., Rössler W., Straub M.,et al:Clinical results of the transurethral resection and evaluation of superficial bladder carcinomas by means of fluorescence diagnosis after intravesical instillation of 5-aminolaevulinic acid. Endourology J Endourol 13:117-121,1999.
24. König F., McGovern FJ, Larne R.,et al:Diagnosis of bladder carcinoma using proroporhyrin IX fluorescence induced by 5-aminolaevulinic acid. Br J Urol International 83:129-135, 1999.
25. Kriegmair M., Zaak D., Stepp M.,et al:Transurethral resection and surveillance of bladder cancer-supported by 5-aminolevulinic acid induced fluorescence endoscopy. Eur Urol (in press).
26. Kriegmair M. und Mitglieder Der AFE-Studiengruppe: Die transurethrale Elektroresektion von Harnblasentumoren mit und ohne 5-Aminolävulinsäure induzierter Fluoreszenz-Endoskopie. Urologe A 37:S15, 1998.
27. Bouffioux Ch, Kurth KH, Bono A.,et al:Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Results of 2 European organisation for research and treatment of cancer randomized trials with Mitomycin C and Doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol 153:934-941, 1995.